RMD Earnings
ResMed next reports earnings on October 29, 2026. Track record: 4/4 beats.
Next Earnings In
Thursday, October 29, 2026
Current Price
$240.33
EPS Estimate
Earnings Per Share
$2.69
+5.4% YoY
Trailing EPS
Last 12 months earnings
$10.62
Beat Rate
4/4
100%Forward P/E
Price-to-Earnings ratio
18.2
Margin: 26.9%
Analyst Rating
16 analysts
Analyst Sentiment
Buy16 analystsEarnings History
| Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| 2026-06-30 | $2.89 | $2.95 | +2.0% | Beat |
| 2026-03-31 | $2.80 | $2.86 | +2.1% | Beat |
| 2025-12-31 | $2.72 | $2.81 | +3.1% | Beat |
| 2025-09-30 | $2.50 | $2.55 | +2.0% | Beat |
Growth Estimates
| Period | EPS Est. | Revenue Est. | Growth |
|---|---|---|---|
| Current Qtr(0q) | $2.69 | $1.4B | +5.4% |
| Next Qtr(+1q) | $3.04 | $1.5B | +8.1% |
| Current Year(0y) | $12.09 | $5.8B | +8.2% |
| Next Year(+1y) | $13.22 | $6.2B | +9.4% |
Next Quarter Estimates
EPS Estimate
Earnings Per Share
$2.69
Revenue Estimate
$1.4B
Annual EPS Est.
$12.09
+8.2% YoY
RMD Earnings FAQ
When is RMD's next earnings date?
ResMed (RMD) is expected to report earnings on October 29, 2026. The consensus EPS estimate is $2.69.
Does RMD usually beat earnings estimates?
ResMed has beaten Wall Street EPS estimates in 4 of the last 4 quarters (100% beat rate).
What is RMD's trailing EPS?
ResMed's trailing twelve-month EPS is $10.62. This is calculated from the last four quarters of reported earnings.
What do analysts think about RMD?
16 Wall Street analysts cover ResMed. The consensus rating is "Buy" with an average price target of $245.50, implying 2.2% upside from the current price.